Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present NovoCure Limited (NASDAQ: NVCR).

Full DD Report for NVCR

You must become a subscriber to view this report.


Recent News from (NASDAQ: NVCR)

Novocure and Zai Lab to Host Investor Event
Novocure (NASDAQ: NVCR) announced today that it will host an investor event with Zai Lab on Nov. 14, 2018, in Shanghai, China. William Doyle, Novocure’s Executive Chairman, Dr. Samantha Du, Zai Lab’s CEO, and Tao Fu, Zai Lab’s President and Chief Operating Officer, will ...
Source: Business Wire
Date: November, 07 2018 16:00
NetworkNewsBreaks - Mizuho Securities Reiterates 'Buy' Rating on NovoCure Limited (NASDAQ: NVCR)
Mizuho Securities USA LLC has reiterated its ‘Buy’ rating and issued a price target of $51 on shares of NovoCure Limited’s (NASDAQ: NVCR) stock. NovoCure is an oncology company engaged in the development of an incomparable cancer treatment employing tumor treating fields. ...
Source: NetworkNewsWire
Date: November, 07 2018 13:15
New Research Coverage Highlights HomeStreet, Cousins Properties, Carbo Ceramics, Cowen Group, CTS, and NovoCure - Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Oct. 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of HomeStreet, Inc. (NASDAQ:HMST), Cousins Properties Incorporated (NYSE:CUZ...
Source: GlobeNewswire
Date: October, 30 2018 07:30
NovoCure Limited (NVCR) CEO Asaf Danziger on Q3 2018 Results - Earnings Call Transcript
NovoCure Limited (NVCR) Q3 2018 Earnings Conference Call October 25, 2018 08:00 AM ET Executives Ashley Cordova - Senior Vice President, Finance and Investor Relations Bill Doyle - Executive Chairman Asaf Danziger - Chief Executive Officer Wilco Groenhuysen - Chief Financial Of...
Source: SeekingAlpha
Date: October, 25 2018 12:40
Midday movers: TWTR, XLNX gain; ALGN, GG lose (10/25/2018)
Gainers:  TIS +20% . TBIO +17% . SNBR +17% . LJPC +17% . ATNI +16% . IMMY +15% . TWTR +15% . XLNX +15% . TRVG +14% . MORN +14% . More news on: Orchids Paper Products Company, Translate Bio, Sleep Number Corporation, Stocks on the move, , Top stock marke...
Source: SeekingAlpha
Date: October, 25 2018 12:34
NovoCure 2018 Q3 - Results - Earnings Call Slides
The following slide deck was published by NovoCure in conjunction with their 2018 Q3 earnings Read more ...
Source: SeekingAlpha
Date: October, 25 2018 11:20
NovoCure Q3 top line up 29%
NovoCure ( NVCR ) Q3 results: Revenues: $64.8M (+29.3%); Net Loss: ($11.7M) (+1.7%); Loss Per Share: ($0.13) (unch). More news on: NovoCure, Healthcare stocks news, Earnings news and commentary, Read more ...
Source: SeekingAlpha
Date: October, 25 2018 06:44
NovoCure beats by $0.02, misses on revenue
NovoCure (NASDAQ: NVCR ): Q3 GAAP EPS of -$0.13 beats by $0.02 . More news on: NovoCure, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: October, 25 2018 06:08
Novocure Reports Third Quarter 2018 Financial Results and Provides Company Update
Quarterly net revenues of $64.8 million, representing 29 percent growth versus the third quarter 2017 and 5 percent growth versus the second quarter 2018 Humanitarian device exemption (HDE) application submitted to FDA for approval in malignant pleural mesothelioma Novocure (NASD...
Source: Business Wire
Date: October, 25 2018 06:00
NovoCure: Projecting Glioblastoma And Mesothelioma Revenues
Shares of NovoCure ( NVCR ) were trading at $18/share when I introduced them as "revolutionizing cancer treatment" and at $21/share when I called them a "high conviction" pick. Just a few months later, shares in NovoCure trade comfortably over $45/share and for good reason. NovoCure is see...
Source: SeekingAlpha
Date: September, 12 2018 11:55

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1447.4048.9049.2547.201,091,065
2018-08-2739.9040.0040.3539.30528,925
2018-08-2439.7040.0040.1539.425789,514
2018-08-2337.6539.4039.7037.65775,711
2018-08-2236.3537.8037.9536.25424,769

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-0761,620109,00156.5316Short
2018-12-06109,464153,53971.2939Short
2018-12-04162,134251,53564.4578Short
2018-12-0382,241163,84450.1947Short
2018-11-3058,938145,94540.3837Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NVCR.


About NovoCure Limited (NASDAQ: NVCR)

Logo for NovoCure Limited (NASDAQ: NVCR)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $2,657,482,692 - 05/18/2018
  • Issue and Outstanding: 90,699,068 - 04/19/2018

 


Recent Filings from (NASDAQ: NVCR)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 12 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: September, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 06 2018
Amendment to a previously filed Form 3
Filing Type: 3/AFiling Source: edgar
Filing Date: August, 28 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 31 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 26 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: July, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 06 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 06 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 01 2018

 

 


Daily Technical Chart for (NASDAQ: NVCR)

Daily Technical Chart for (NASDAQ: NVCR)


Stay tuned for daily updates and more on (NASDAQ: NVCR)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: NVCR)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NVCR is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NVCR and does not buy, sell, or trade any shares of NVCR. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/